1. Miksinski SP. New drug applications: the evolution of quality review, in 2nd FDA/PQRI Conference on advancing product quality. 2015: Bethesda, MD.
2. Selen A, Dickinson PA, Müllertz A, Crison JR, Mistry HB, Cruañes MT, et al. The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance. J Pharm Sci. 2014;103(11):3377–97.
3. United States Pharmacopeia and the National Formulary (USP-NF). Chapter 711 in US Pharmacopeial Convention. 2015. Rockville, MD.
4. Takeuchi S, Tsume Y, Amidon GE, Amidon GL. Evaluation of a three compartment in vitro gastrointestinal simulator dissolution apparatus to predict in vivo dissolution. J Pharm Sci. 2014;103(11):3416–22.
5. U.S. Department of Health and Human Services—Food and Drug Administration, CDER., Guidance for industry—dissolution testing of immediate release solid oral dosage forms. 1997.